A carregar...
Exploring potential biomarkers for lung adenocarcinoma using LC-MS/MS metabolomics
BACKGROUND: The average 5-year survival rate of lung adenocarcinoma patients is only 15% to 17%, which is primarily due to late-stage diagnosis and a lack of specific prognostic evaluations that can recommend effective therapies. Additionally, there is no clinically recognized biomarker that is effe...
Na minha lista:
| Publicado no: | J Int Med Res |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7177994/ https://ncbi.nlm.nih.gov/pubmed/32316791 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0300060519897215 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|